On the stock market since 2019, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
The biggest line carries real weight, but it doesn’t decide everything on its own.
An average decline of 100% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.
It pays out $0.29 per share each year — regular cash for whoever holds the stock.
A loss of $174.5M against $0 in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.55. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, AGBAR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: AGBAR is a high-risk stock — not yet profitable, and its future rides on its product catching on.